Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2003 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: GEODON

« Back to Dashboard

Summary for Tradename: GEODON

Patents:6
Applicants:1
NDAs:2
Suppliers: see list10

Pharmacology for Tradename: GEODON

Clinical Trials for: GEODON

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
Status: Completed Condition: Major Depressive Disorder

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
Status: Completed Condition: Schizophrenia

Geodon for the Treatment of Refractory Social Anxiety Disorder
Status: Completed Condition: Social Anxiety Disorder

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
Status: Completed Condition: Healthy

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
Status: Completed Condition: Healthy

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
Status: Completed Condition: Depression, Bipolar

Geodon in Weight Loss Study for Bipolar Disorders
Status: Completed Condition: Bipolar Disorder

Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
Status: Terminated Condition: Generalized Anxiety Disorder; Bipolar Disorder

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
Status: Completed Condition: Schizophrenia; Bipolar Disorder; Schizoaffective Disorder

Ziprasidone in Pediatric Bipolar Disorder
Status: Completed Condition: Bipolar Disorder

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Pfizer
GEODON
ziprasidone hydrochloride
Capsule; Oral020825FEB 05, 2001RXNo<disabled><disabled>
Pfizer
GEODON
ziprasidone mesylate
Injectable; Intramuscular020919JUN 21, 2002RXYes<disabled><disabled>
Pfizer
GEODON
ziprasidone hydrochloride
Capsule; Oral020825FEB 05, 2001RXNo4,831,031<disabled><disabled>
Pfizer
GEODON
ziprasidone mesylate
Injectable; Intramuscular020919JUN 21, 2002RXYes6,110,918<disabled><disabled>
Pfizer
GEODON
ziprasidone hydrochloride
Capsule; Oral020825FEB 05, 2001RXYes6,150,366<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: GEODON

Drugname Dosage Strength RLD Submissiondate
ziprasidone hydrochlorideCapsules20 mg, 40 mg, 60 mg and 80 mgGeodon2/7/2005
« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc